Inactive Instrument

Calendar Caladrius Biosciences Inc Nasdaq

Equities

US1280581042

End-of-day quote Nasdaq
- USD - Intraday chart for Caladrius Biosciences Inc

Chart calendar Caladrius Biosciences Inc

bff906d0f91d9811f4bc018de3.-U_OVHk4chrvLOi-Ueu7klrynkFjprC3x5BHI-ZVnmI.sHiqE0hhPk2_TaPSN6_xqjuA1ncP9YjigMlyQawn6gadAqYzCggoKq0BvQ~ae129663f5b32d2b3afd39538ac735f6

Upcoming events on Caladrius Biosciences Inc

13/05/2024 Pharma Partnering U.S. Summit
14/05/2024 BioNJ BioPartnering Conference
22/05/2024 11:30 Pharma Partnering EU Summit
30/05/2024 American Society of Clinical Oncology Annual Meeting
31/05/2024 16:50 Oncology Innovation Forum
11/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
06/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Caladrius Biosciences Inc

09/05/2024 21:30 Q1 2024 Earnings Call
09/05/2024 21:05 Q1 2024 Earnings Release
23/04/2024 16:30 Immuno Oncology Europe Summit
17/04/2024 18:30 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
10/04/2024 17:00 FORCE Family Office Healthcare Conference
09/04/2024 15:00 LD Micro Invitational Conference
07/03/2024 15:30 OTC Markets Life Science Investor Forum
29/02/2024 21:30 Q4 2023 Earnings Call
29/02/2024 21:05 Q4 2023 Earnings Release
26/02/2024 16:15 BIO CEO & Investor Conference
24/01/2024 14:00 Sequire Investor Summit
16/01/2024 FORCE Family Office Healthcare Conference
04/12/2023 15:00 Noble Capital Markets Emerging Growth Equity Conference
30/11/2023 02:00 GCFF Healthcare Investment Conference
13/11/2023 Jefferies London Healthcare Conference
13/11/2023 14:30 LSX Inv€$tival Showcase
09/11/2023 05:00 FORCE Family Office Healthcare Conference
02/11/2023 20:30 Q3 2023 Earnings Call
02/11/2023 20:05 Q3 2023 Earnings Release
05/10/2023 15:00 Bio Future Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-19,1
-19,3
1.13%
-29,0
-30,4
4.62%
-57,5
-59,3
2.98%
-25,5
-27,6
7.54%

-28,8

EBIT
Million USD
Released
Forecast
Spread
-20,1
-19,7
-1.99%
-19,1
-18,4
-3.8%
-29,1
-30,5
4.7%
-57,6
-43,7
-31.75%
-25,7
-27,2
5.34%

-28,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-19,4
-19,0
-1.9%
-19,0
-18,3
-4.04%
-29,0
-30,4
4.68%
-56,7
-58,8
3.56%
-23,2
-24,7
6.33%

-25,9

Net income
Million USD
Released
Forecast
Spread
-19,4
-18,9
-2.44%
-8,15
-12,9
36.7%
-27,5
-29,6
7.34%
-54,2
-56,3
3.69%
-20,8
-23,6
11.65%

-25,9

EPS
USD
Released
Forecast
Spread
-28,2
-27,4
-2.73%
-7,95
-12,2
34.97%
-7,50
-8,25
9.09%
-10,5
-10,9
3.86%
-2,58
-2,91
11.34%

-3,08

Announcement Date05/03/2025/02/2122/03/2230/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread
-6,84
-8,20
16.57%
-6,61
-7,00
5.53%
-6,71
-7,60
11.67%
-7,32
-7,10
-3.08%
-6,49
-8,30
21.76%
-6,80
-6,60
-2.97%
-6,83
-7,10
3.83%
-5,92
-7,90
25.1%
-5,98
-8,00
25.28%
-6,56
-6,40
-2.42%

-6,80


-7,20


-8,40

EBIT
Million USD
Released
Forecast
Spread
-6,85
-8,36
18.09%
-6,62
-7,19
7.94%
-6,72
-6,85
1.91%
-7,33
-6,95
-5.39%
-6,54
-7,47
12.48%



-6,88
-7,17
4.05%
-5,96
-7,89
24.42%
-6,03
-7,52
19.85%
-6,60
-6,91
4.49%

-6,91


-6,91


-6,91

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,79
-8,21
17.21%
-6,71
-7,08
5.24%
-6,63
-7,19
7.9%
-37,4
-6,98
-435.61%
-5,99
-8,10
26.04%
-6,19
-6,60
6.26%
-6,36
-6,79
6.38%
-5,26
-7,57
30.46%
-5,37
-7,02
23.59%
-6,20
-6,06
-2.27%

-6,26


-6,46


-7,11

Net income
Million USD
Released
Forecast
Spread
-6,79
-8,96
24.14%
-4,23
-7,08
40.28%
-6,63
-7,19
7.9%
-37,4
-6,98
-435.61%
-5,99
-8,10
26.04%
-6,19
-6,60
6.26%
-4,03
-5,69
29.23%
-5,26
-7,57
30.46%
-5,37
-7,02
23.59%
-5,40
-6,06
10.9%

-6,26


-6,46


-7,11

EPS
USD
Released
Forecast
Spread
-1,65
-2,25
26.67%
-1,05
-1,73
39.13%
-1,65
-1,73
4.35%
-7,88
-1,28
-518.04%
-0,76
-1,02
25.49%
-0,77
-0,81
4.94%
-0,50
-0,70
28.57%
-0,65
-0,93
30.11%
-0,66
-0,86
22.81%
-0,65
-0,73
10.34%

-0,75


-0,77


-0,84

Announcement Date22/03/2205/05/2204/08/2210/11/2230/03/2309/05/2314/08/2302/11/2329/02/2409/05/24---
  1. Stock Market
  2. Equities
  3. LSTA Stock
  4. Stock
  5. Calendar Caladrius Biosciences Inc